MediciNova, Inc. – Severance Agreement and Release (September 26th, 2013)
This Severance Agreement and Release (Agreement), is entered into by and between Kirk Johnson, Ph.D. (Johnson) and MediciNova, Inc., a Delaware corporation (the Company), with regard to the following:
MediciNova, Inc. – Sixth Amendment (March 22nd, 2012)
THIS SIXTH AMENDMENT (the Amendment) is made and entered into as of March 19, 2012, by and between 4350 LA JOLLA VILLAGE LLC, a Delaware limited liability company, (Landlord) and MEDICINOVA, INC., a Delaware corporation (Tenant).
MediciNova, Inc. – EXECUTIVE EMPLOYMENT AGREEMENT Kirk Johnson (February 1st, 2010)
This EXECUTIVE EMPLOYMENT AGREEMENT (this Agreement) is made as of February 1, 2010 by and between MEDICINOVA, INC, a Delaware corporation (MediciNova), and Kirk Johnson (Executive), with reference to the following facts:
Avigen, Inc. – Executive Officer Cash Compensation Arrangements (March 16th, 2009)
Name Position Salary Kenneth Chahine, J.D., Ph.D. President, Chief Executive $ 443,251 Officer and Director Michael Coffee Chief Business Officer $ 313,903 Kirk Johnson, Ph.D. Vice President, Research and $ 278,528 Development Andrew Sauter Chief Financial Officer $ 267,931 M. Christina Thomson, J.D. Vice President, General $ 267,931 Counsel and Secretary
Avigen, Inc. – Compensation Agreements With Named Executive Officers (November 8th, 2007)
The following are the annual salaries of our named executive officers as amended by the Compensation Committee (the Committee) of the Board of Directors effective September 16, 2007.
Avigen, Inc. – Contract (March 16th, 2005)